ALIGNMENT HEALTHCARE, INC. vs CLOVER HEALTH INVESTMENTS, CORP. /DE, two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where ALHC and CLOV diverge most: on net margin, ALHC reads 0.9% and CLOV reads -2.6%; on return on equity, ALHC reads 15.3% and CLOV reads -16.8%. The rest of the comparable metrics sit closer together. What ALHC's price implies is an extreme bet versus history and the cohort (earnings-power basis). What CLOV's price implies is an extreme bet versus history and the cohort (earnings-power basis). The bull and bear cases for each are in their full reports below.
| Metric | ALHC | CLOV |
|---|---|---|
| Price | $14.86 | $4.16 |
| Market cap | $3.1B | $2.2B |
| Sector | Managed Care | Managed Care |
| Stage | Growth | Growth |
| P/B | 11.63 | 6.53 |
| P/S | 0.67 | 1.00 |
| EV/EBITDA | 31.4 | — |
| Revenue growth | +38.2% | +47.7% |
| Operating margin | 3.1% | 3.6% |
| Net margin | 0.9% | -2.6% |
| Return on equity | 15.3% | -16.8% |
| Return on assets | 3.2% | -8.2% |
| Return on invested capital | 9.0% | -13.3% |
| FCF yield | 5.8% | 2.5% |
| Debt / equity | 1.22 | 0.00 |
| Current ratio | 1.70 | 1.33 |
| Altman Z (solvency) | 4.91 | 2.66 |
| Piotroski F (quality) | 5 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.